About this episode:
In this podcast, Dr Penny Heaton, Global Head of the Johnson and Johnson Office of the Chief Medical Officer, discusses:
- J&J’s approach to patient centricity across the enterprise
- Her thoughts on balancing balancing safety and risk/benefit ratios with more engaged patients and more complex science
- Moving risk benefit assessments earlier into clinical development and the necessary change management
- Incorporating multiple streams of data for the purpose of creating medicines that truly address patient needs in the real world
For more information, go to patientsaspartnersconference.com.
Related Podcasts
View All
The Role of Patient Organizations in Increasing Representation at the Clinical Trial Site Level
Merck on Enhancing Trial Participation, Relevance, and Impact through Patient and Community Engagement
Ensuring Continuity in Patient Insights to Strengthen Medicine Development


